Annual Net Margin
-16.88 K%
-16.80 K%-19698.72%
30 September 2024
Summary:
Arrowhead Pharmaceuticals annual net profit margin is currently -16.88 thousand%, with the most recent change of -16.80 thousand% (-19698.72%) on 30 September 2024. During the last 3 years, it has fallen by -16.78 thousand% (-16475.72%). ARWR annual net margin is now -42022.95% below its all-time high of 40.27%, reached on 30 September 2019.ARWR Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
N/A
30 September 2024
Summary:
Arrowhead Pharmaceuticals quarterly net profit margin is not available.ARWR Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARWR Net Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -10000.0% | - |
3 y3 years | -10000.0% | - |
5 y5 years | -10000.0% | - |
ARWR Net Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | <-9999.0% | at low | ||
5 y | 5 years | <-9999.0% | at low | ||
alltime | all time | <-9999.0% | +67.3% |
Arrowhead Pharmaceuticals Net Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | -16.88 K%(>+9900.0%) | - |
Dec 2023 | - | -3741.59%(+449.1%) |
Sept 2023 | -85.27%(+17.8%) | -681.36%(+4.7%) |
June 2023 | - | -650.53%(-2054.7%) |
Mar 2023 | - | 33.28%(-150.4%) |
Dec 2022 | - | -66.07%(-75.6%) |
Sept 2022 | -72.39%(-28.9%) | -270.82%(+21.8%) |
June 2022 | - | -222.28%(-860.5%) |
Mar 2022 | - | 29.23%(-112.8%) |
Dec 2021 | - | -229.13%(+38.4%) |
Sept 2021 | -101.85%(+6.0%) | -165.54%(+153.9%) |
June 2021 | - | -65.21%(-20.2%) |
Mar 2021 | - | -81.73%(-16.0%) |
Dec 2020 | - | -97.32%(-84.7%) |
Sept 2020 | -96.09%(-338.6%) | -634.52%(+1176.2%) |
June 2020 | - | -49.72%(-41.0%) |
Mar 2020 | - | -84.30%(+829.4%) |
Dec 2019 | - | -9.07%(-133.5%) |
Sept 2019 | 40.27%(-111.9%) | 27.04%(-43.2%) |
June 2019 | - | 47.63%(-4.0%) |
Mar 2019 | - | 49.63%(+42.9%) |
Dec 2018 | - | 34.73%(-136.3%) |
Sept 2018 | -337.32%(+208.2%) | -95.61%(-95.5%) |
June 2018 | - | -2145.53%(-6.3%) |
Mar 2018 | - | -2289.45%(+508.8%) |
Dec 2017 | - | -376.06%(+205.3%) |
Sept 2017 | -109.46%(-99.8%) | -123.16%(+108.5%) |
June 2017 | - | -59.08%(-12.1%) |
Mar 2017 | - | -67.24%(-75.7%) |
Dec 2016 | - | -276.86%(-99.6%) |
Sept 2016 | -51.61 K%(+114.5%) | -71.11 K%(+44.9%) |
June 2016 | - | -49.06 K%(+3.1%) |
Mar 2016 | - | -47.58 K%(+8.1%) |
Dec 2015 | - | -44.03 K%(-22.1%) |
Sept 2015 | -24.07 K%(-28.2%) | -56.56 K%(+339.2%) |
June 2015 | - | -12.88 K%(-80.4%) |
Mar 2015 | - | -65.56 K%(+395.9%) |
Dec 2014 | - | -13.22 K%(-74.2%) |
Sept 2014 | -33.50 K%(+212.3%) | -51.27 K%(+92.9%) |
June 2014 | - | -26.58 K%(-16.6%) |
Mar 2014 | - | -31.87 K%(+31.2%) |
Dec 2013 | - | -24.29 K%(-22.4%) |
Sept 2013 | -10.73 K% | -31.30 K%(+125.2%) |
June 2013 | - | -13.89 K%(-10.0%) |
Mar 2013 | - | -15.45 K%(+432.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | - | -2901.69%(-76.1%) |
Sept 2012 | -14.38 K%(+1261.4%) | -12.15 K%(-27.2%) |
June 2012 | - | -16.68 K%(-2.3%) |
Mar 2012 | - | -17.07 K%(+64.6%) |
Dec 2011 | - | -10.37 K%(+2036.9%) |
Sept 2011 | -1056.56%(+105.6%) | - |
Dec 2010 | - | -485.48%(+945.4%) |
Mar 2010 | - | -46.44%(-95.5%) |
Dec 2009 | - | -1043.39%(-43.4%) |
Sept 2009 | -513.77%(-75.3%) | -1844.53%(+1820.8%) |
June 2009 | - | -96.03%(-95.7%) |
Mar 2009 | - | -2244.55%(+96.1%) |
Dec 2008 | - | -1144.39%(-64.1%) |
Sept 2008 | -2078.65%(-16.1%) | - |
June 2008 | - | -3187.36%(+308.4%) |
Mar 2008 | - | -780.36%(-39.9%) |
Dec 2007 | - | -1299.15%(-0.8%) |
Sept 2007 | -2477.70%(-22.3%) | -1310.07%(-34.6%) |
June 2007 | - | -2004.11%(-94.0%) |
Dec 2006 | - | -33.42 K%(+104.7%) |
Sept 2006 | -3190.35%(+174.9%) | -16.33 K%(+878.0%) |
June 2006 | - | -1669.76%(-81.5%) |
Mar 2006 | - | -9033.99%(+627.2%) |
Dec 2005 | - | -1242.36%(-9.1%) |
Sept 2005 | -1160.51%(-9.9%) | -1366.50%(-20.1%) |
June 2005 | - | -1711.27%(+41.8%) |
Dec 2004 | - | -1206.59%(+27.3%) |
Sept 2004 | -1287.86%(-88.1%) | -947.89%(-44.7%) |
June 2004 | - | -1715.56%(-93.4%) |
June 2003 | - | -25.85 K%(+115.9%) |
Mar 2003 | - | -11.97 K%(+316.5%) |
Dec 2002 | - | -2874.31%(-97.0%) |
Sept 2002 | -10.87 K%(+444.5%) | -95.19 K%(+191.8%) |
June 2002 | - | -32.62 K%(+1683.3%) |
Mar 2002 | - | -1829.37%(-60.9%) |
Dec 2001 | - | -4678.25%(-44.7%) |
Sept 2001 | -1995.50%(+260.9%) | -8464.72%(+754.8%) |
June 2001 | - | -990.23%(-98.2%) |
Mar 2001 | - | -54.09 K%(+6787.8%) |
Dec 2000 | - | -785.35%(-34.1%) |
Sept 2000 | -552.91%(+102.3%) | - |
June 2000 | - | -1192.27%(+45.5%) |
Mar 2000 | - | -819.58%(-32.3%) |
Dec 1999 | - | -1210.61% |
Sept 1998 | -273.32%(-75.5%) | - |
Sept 1997 | -1115.73% | - |
FAQ
- What is Arrowhead Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual net margin year-on-year change?
- What is the all time high quarterly net margin for Arrowhead Pharmaceuticals?
What is Arrowhead Pharmaceuticals annual net profit margin?
The current annual net margin of ARWR is -16.88 K%
What is the all time high annual net margin for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual net profit margin is 40.27%
What is Arrowhead Pharmaceuticals annual net margin year-on-year change?
Over the past year, ARWR annual net profit margin has changed by -16.80 K% (-19698.72%)
What is the all time high quarterly net margin for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly net profit margin is 49.63%